The Global Injectable Drug Delivery Technology Market for Therapeutics - Outlook to 2023: Increasing Prevalence of Chronic Diseases to Boost the Market - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 20, 2018--The “Global Injectable Drug Delivery Technology Market for Therapeutics - Segmented by Type, Application, Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.
The global injectable drug delivery technology market for therapeutics is expected to witness a CAGR of 10.67%, during the forecast period.
Increasing Prevalence of Chronic Diseases to Boost the Market
According to Centers for Disease Control and Prevention (CDC), in United States seven of the top 10 causes of death in 2014 were chronic diseases. Cancer and heart diseases together accounted for an approximate of 46 percent of all deaths. It has also reported that about half of the adults in United States had one or more chronic conditions and one if four had more than two chronic conditions. Moreover, this number is expected to increase in the next 10 years.
Since, the adoption rate of injectable drug delivery devices is high among the population suffering from diseases, like diabetes and heart related disorders, the increasing prevalence of chronic diseases is expected to contribute for the growth of injectable drug delivery technology market in the forecast period.
The convenience in handling syringes and the automation of dispensing the drug in exact proportions is also contributing to the growth of the market.
Other Key HighlightsInjuries & Infections Caused by Needles is Restraining Growth North America is Expected to Hold the Largest Share of the Market
Notable Development in the MarketApril 2017: BD (Becton, Dickinson and Company) and C. R. Bard, Inc. has entered into a definitive agreement
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key PlayersBecton Dickinson Baxter International Pfizer Gerresheimer AG Terumo Corporation Eli Lily & Company Schott AG
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/zlm2pq/the_global?w=4.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180820005367/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infusions and Injectables
KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA AFRICA MIDDLE EAST
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES MEDICAL SUPPLIES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/20/2018 10:18 AM/DISC: 08/20/2018 10:18 AM